Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vencovsky, J.
Right arrow Articles by Mageed, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vencovsky, J.
Right arrow Articles by Mageed, R. A.
Related Collections
Right arrow Immunogenetics
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 401-410
© 2002 British Society for Rheumatology


Original Papers

Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope

J. Vencovsky1, E. Zd’ársky, S. P. Moyes2, A. Hajeer3, S. Ruzicková1, Z. Cimburek, W. E. Ollier3, R. N. Maini2 and R. A. Mageed4,

Institute of Rheumatology, Na slupi 4, Prague and
1 Laboratory of Gene Expression, Charles University, Prague, Czech Republic,
2 Kennedy Institute of Rheumatology, London,
3 ARC Epidemiology Unit, Manchester and
4 Department of Immunology and the Centre for Rheumatology, University College London, London, UK

Objective. To investigate the contribution of polymorphism in the immunoglobulin heavy chain variable region V1-69 gene set to genetic susceptibility to rheumatoid arthritis (RA) in Czech and British patients.

Methods. We used V1-69 gene sequence-specific polymerase chain reaction (PCR) and restriction enzyme digestion to study polymorphism in the V1-69 gene set in germline DNA of 109 Czech and 159 British RA patients and 164 ethnically matched controls. Polymorphism was further studied by nucleotide sequencing of the V1-69 gene locus in germline DNA.

Results. We found that all patients and controls had at least one V1-69 gene copy. In the Czech RA cohort, the dimorphic nucleotide in codon 73 of V1-69 (GAA or AAA) was present in the homozygous form 73A/A in 31 of 109 (28.4%) RA patients vs 12 of 79 (15.2%) controls [odds ratio (OR)=2.22, P<0.001]. When the RA patients and controls were classified according to HLA shared epitope (SE) status, 73A/A was found in 18 of 76 (23.7%) SE+ patients compared with 13 of 38 (34.2%) SE- patients, four of 12 (18.2) SE+ controls and eight of 57 (14%) SE- controls. This suggests that homozygosity for the dimorphic sequence 73A contributed to susceptibility to RA in SE- Czech individuals (OR=3.2, P<0.001). The most striking observation was that none of the 38 SE- Czech patients, compared with 11 of 76 (14.5%) SE+ RA patients, three of 22 (13.6%) SE+ and 11 of 57 (19.3%) SE- ethnically matched controls, were homozygous for the alternative dimorphic sequence 73G/G (OR=9.1, P<0.05). These data, however, were not replicated in a Caucasoid British RA population.

Conclusion. The dimorphic sequence at codon 73 (73A/A) of the V1-69 gene contributes to genetic susceptibility in SE- Czech RA patients.

KEY WORDS: Immunoglobulins, Immunogenetics, Rheumatoid arthritis.

Correspondence to: R. A. Mageed, Department of Immunology, The Windeyer Institute of Medical Sciences, 46 Cleveland Street, London W1T 4JF, UK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.